Tesamorelin 10mg

Modified GHRH analog — 44 amino acids with N-terminal trans-3-hexenoic acid modification Lipophilic modification protects against aminopeptidase degradation in experimental models Research-grade · CAS 218949-48-5 For in vitro GHRH receptor research only

$91.99 In stock

Research-Grade CompoundsManufactured to research-grade standards for laboratory research use only.

Discreet ShippingEvery order ships in plain, protective packaging.

In-House FulfillmentOrders are inspected, packed, and shipped directly by the Heritage Labs team.

Same-day dispatch on orders before 12:00 PM ET, Mon–Fri. Discreet, plain packaging.

In-House Fulfillment Orders are inspected, packed, and shipped directly by the Heritage Labs team.

View Certificates of Analysis →

SSL 256-bit Secure Checkout

For laboratory research use only. Not for human or veterinary consumption. SKU TSM10.

Overview

Product details.

Tesamorelin 10mg — Modified GHRH Analog

Tesamorelin takes a fundamentally different approach to GHRH stabilization than CJC-1295. Instead of swapping amino acids to resist DPP-IV, it caps the N-terminus with a lipophilic trans-3-hexenoic acid group that blocks aminopeptidase access. And instead of truncating to 29 amino acids, it keeps all 44 — the full native GHRH sequence with protection bolted on.

Research-Grade Compounds

Manufactured to research-grade standards for laboratory research use only.

Discreet Shipping

Every order ships in plain, protective packaging.

In-House Fulfillment

Orders are inspected, packed, and shipped directly by the Heritage Labs team.

Specifications

Amino Acids	44
Modification	N-terminal trans-3-hexenoic acid
Molecular Weight	5135.83 g/mol
CAS Number	218949-48-5
Form	Lyophilized powder
Quantity	10mg per vial

Three ways to stabilize GHRH

Sermorelin: no modifications, short half-life (~11 min), clean pulsatile release. CJC-1295 No DAC: four amino acid substitutions, moderate half-life (30 min-2 hours). Tesamorelin: full-length sequence with lipophilic N-terminal cap. Three different engineering philosophies applied to the same receptor target. Heritage Labs USA stocks all three.

Research context

Protease assays have confirmed that the trans-3-hexenoic acid group provides effective aminopeptidase resistance. Published studies have examined Tesamorelin in pituitary GHRH receptor signaling, somatotroph response kinetics, and head-to-head comparisons with Sermorelin and CJC-1295.

Frequently paired with

Ipamorelin 10mg — Available as Ipa/Tesa Blend.

Quality and testing

Every Heritage Labs compound is manufactured to research-grade standards and shipped in protective packaging.

Storage

Lyophilized: -20°C
Reconstituted: 2-8°C, use within 30 days

For laboratory research use only. Not for human or veterinary use.

For laboratory research use only. Not for human or veterinary use. This product is not a drug or supplement and is not intended to diagnose, treat, cure, or prevent any disease.

FDA DISCLAIMER: All products are intended for research use only as defined by the FDA. Not for use in diagnostic procedures, human use, or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. All products sold by Heritage Labs are intended strictly for laboratory research, analytical, or in-vitro purposes only. Heritage Labs operates as a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Heritage Labs is not classified as an outsourcing facility under Section 503B of the same Act. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.